Dendritic cells and T lymphocyte interactions in patients with lymphoid malignancies
/in Chronic Leukemia, International Publications, Malignant Lymphoma /von 2007-05-30 / Physiol Res 2008;57(2):289-98Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
/in Hepatocellular Carcinoma, International Publications /von 2007-05-24 / Cancer Immunol. Immunother. 2007 Dec;56(12):1931-43Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells
/in Dendritic Cells, International Publications, NSCLC /von 2007-05-16 / Lung Cancer 2007 Sep;57(3):365-72Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer
/in International Publications, Ovarian Cancer /von 2007-05-01 / Lancet Oncol. 2007 May;8(5):451-4AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients
/in Hepatocellular Carcinoma, International Publications /von 2007-05-01 / J. Immunother. 2007 May-Jun;30(4):425-37[Changes of dendritic cells in prostate cancer and dendritic cell-based immunotherapy]
/in International Publications, Prostate Cancer /von 2007-05-01 / Zhonghua Nan Ke Xue 2007 May;13(5):453-6TGF-beta insensitive dendritic cells: an efficient vaccine for murine prostate cancer
/in International Publications, Prostate Cancer /von 2007-05-01 / Cancer Immunol. Immunother. 2007 Nov;56(11):1785-93On verification of hyperthermia treatment planning for cervical carcinoma patients
/in Cervical Cancer, International Publications /von 2007-05-01 / Int J Hyperthermia 2007 May;23(3):303-14Prediction of anti-tumour effect of thermochemotherapy with in vitro thermochemosensitivity testing for non-small cell lung cancer
/in International Publications, NSCLC /von 2007-05-01 / Int J Hyperthermia 2007 May;23(3):267-75
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution